title: Cyclotide-membrane interactions: defining factors of membrane binding, depletion and disruption.
abstract: The cyclotide family of plant-derived peptides is defined by a cyclic backbone and three disulfide bonds locked into a cyclic cystine knot. They display a diverse range of biological activities, many of which have been linked to an ability to target biological membranes. In the current work, we show that membrane binding and disrupting properties of prototypic cyclotides are dependent on lipid composition, using neutral (zwitterionic) membranes with or without cholesterol and/or anionic lipids. Cycloviolacin O2 (cyO2) caused potent membrane disruption, and showed selectivity towards anionic membranes, whereas kalata B1 and kalata B2 cyclotides were significantly less lytic towards all tested model membranes. To investigate the role of the charged amino acids of cyO2 in the membrane selectivity, these were neutralized using chemical modifications. In contrast to previous studies on the cytotoxic and antimicrobial effects of these derivatives, the Glu6 methyl ester of cyO2 was more potent than the native peptide. However, using membranes of Escherichia coli lipids gave the opposite result: the activity of the native peptide increased 50-fold. By using a combination of ellipsometry and LC-MS, we demonstrated that this unusual membrane specificity is due to native cyO2 extracting preferentially phosphatidylethanolamine-lipids from the membrane, i.e., PE-C16:0/cyC17:0 and PE-C16:0/C18:1.
authors.affiliation: Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. Robert.Burman@fkog.uu.se
authors.forename: Robert
authors.initials: R
authors.lastname: Burman
authors.forename: Adam A
authors.initials: AA
authors.lastname: Strömstedt
authors.forename: Martin
authors.initials: M
authors.lastname: Malmsten
authors.forename: Ulf
authors.initials: U
authors.lastname: Göransson
mesh_terms: D000595:Amino Acid Sequence; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000737:chemistry* / Q000187:drug effects*; D002853:Chromatography, Liquid; D002942:Circular Dichroism; D047169:Cyclotides / Q000009:adverse effects / Q000737:chemistry* / Q000494:pharmacology*; D019073:HT29 Cells; D006801:Humans; D008081:Liposomes / Q000737:chemistry; D013058:Mass Spectrometry; D008958:Models, Molecular; D008969:Molecular Sequence Data; D017433:Protein Structure, Secondary; D017386:Sequence Homology, Amino Acid; D013329:Structure-Activity Relationship; D020298:U937 Cells
chemical_list: D047169:Cyclotides; D008081:Liposomes; C091930:kalata B1; C561323:kalata B2; C473355:cycloviolacin O2